Filing Details
- Accession Number:
- 0001415889-23-004096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 16:15:30
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 16:15:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726419 | Stephany Verstraete | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Marketing Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-01 | 5,614 | $0.00 | 37,442 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 2,254 | $25.36 | 35,188 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 1,807 | $0.00 | 36,995 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 3,072 | $0.00 | 40,067 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 772 | $0.00 | 40,839 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 1,147 | $0.00 | 41,986 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 867 | $0.00 | 42,853 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 437 | $0.00 | 43,290 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-03-01 | 5,614 | $0.00 | 5,614 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-03-02 | 1,807 | $0.00 | 1,807 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-03-02 | 3,072 | $0.00 | 3,072 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-03-02 | 772 | $0.00 | 772 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-03-02 | 1,147 | $0.00 | 1,147 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-03-02 | 867 | $0.00 | 867 | $0.00 |
| Common Stock | Performance Stock Units | Acquisiton | 2023-03-02 | 874 | $0.00 | 874 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-03-02 | 437 | $0.00 | 437 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,230 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 1,148 | No | 4 | M | Direct | ||
| 867 | No | 4 | M | Direct | ||
| 874 | No | 4 | A | Direct | ||
| 437 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021
- On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
- On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.
- The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.
- On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
Billionaire Hedge Funds
